ATE83773T1 - 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a. - Google Patents

3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.

Info

Publication number: ATE83773T1
Authority: AT; Austria
Prior art keywords: hydrogen; alkyl; branched; straight chained; pyridazinone
Prior art date: 1987-01-20

Application number

AT88100798T

Other languages

English (en)

Inventor

Keizo Tanikawa

Ryozo Sakoda

Ken-Ichi Shikada

Original Assignee

Nissan Chemical Ind Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-01-20

Filing date

1988-01-20

Publication date

1993-01-15

1988-01-20 Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd

1993-01-15 Application granted granted Critical

1993-01-15 Publication of ATE83773T1 publication Critical patent/ATE83773T1/de

Links

AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical compound OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 11
239000001257 hydrogen Substances 0.000 abstract 11
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 10
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 6
229910052736 halogen Chemical group 0.000 abstract 3
150000002367 halogens Chemical group 0.000 abstract 3
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 2
125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Chemical group 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
125000001309 chloro group Chemical group Cl* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
239000011593 sulfur Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT88100798T 1987-01-20 1988-01-20 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a. ATE83773T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP1023187		1987-01-20
EP88100798A EP0275997B1 (de)	1987-01-20	1988-01-20	3(2H)Pyridazinon, Verfahren zu dessen Herstellung und dieses enthaltendes Mittel gegen SRS-A

Publications (1)

Publication Number	Publication Date
ATE83773T1 true ATE83773T1 (de)	1993-01-15

Family

ID=11744513

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88100798T ATE83773T1 (de)	1987-01-20	1988-01-20	3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.

Country Status (10)

Country	Link
US (1)	US4978665A (de)
EP (1)	EP0275997B1 (de)
AT (1)	ATE83773T1 (de)
AU (1)	AU597141B2 (de)
CA (1)	CA1324792C (de)
DD (1)	DD287497A5 (de)
DE (2)	DE3876813D1 (de)
HU (1)	HU198696B (de)
SU (1)	SU1584750A3 (de)
ZA (1)	ZA88309B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0186817B1 (de) *	1984-12-10	1989-08-02	Nissan Chemical Industries Ltd.	3(2H)Pyridazinon, Verfahren zu seiner Herstellung und dieses enthaltendes anti-allergisches Mittel
IE62890B1 (en) *	1988-12-06	1995-03-08	Hafslund Nycomed Pharma	New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
JPH02256668A (ja) *	1988-12-20	1990-10-17	Nissan Chem Ind Ltd	ピリダジノン誘導体
DE4009761A1 (de) *	1989-07-28	1991-01-31	Bayer Ag	2h-pyridazinon-derivate
ES2149761T3 (es) *	1990-04-25	2000-11-16	Nissan Chemical Ind Ltd	Derivado de piridazinona.
JPH0517357A (ja) *	1991-07-05	1993-01-26	Nissan Chem Ind Ltd	血小板減少療法剤
IL110040A (en) *	1993-06-29	2000-07-16	Nissan Chemical Ind Ltd	Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them
AU681694B2 (en) *	1993-09-06	1997-09-04	Ishihara Sangyo Kaisha Ltd.	Pyridazinone derivatives or their salts, processes for theirproduction, and anti-shock agents containing them
NZ270130A (en) *	1993-12-16	1995-12-21	Nihon Nohyaku Co Ltd	Pyridazinone derivatives, preparation and pharmaceutical compositions thereof
DK0742211T3 (da) *	1994-01-25	2000-08-14	Nissan Chemical Ind Ltd	Pyridazinonderivater
IL112695A (en) *	1994-02-22	1999-04-11	Green Cross Corp	Pharmaceutical compositions containing pyridazinone derivatives
DE19516350A1 (de) *	1995-05-04	1996-11-07	Du Pont Deutschland	Photothermographisches lichtempfindliches Aufzeichnungsmaterial mit vermindertem Schleier
WO2000033845A1 (en) *	1998-12-07	2000-06-15	Nissan Chemical Industries, Ltd.	Remedial agent for erectile dysfunction
US7132445B2 (en)	2001-04-16	2006-11-07	Schering Corporation	3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
US20040106794A1 (en)	2001-04-16	2004-06-03	Schering Corporation	3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
JP2005505595A (ja)	2001-10-12	2005-02-24	シェーリング　コーポレイション	Ｃｘｃ−ケモカインレセプターアンタゴニストとしての３，４−二置換マレイミド化合物
US6878709B2 (en)	2002-01-04	2005-04-12	Schering Corporation	3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
WO2003080053A1 (en)	2002-03-18	2003-10-02	Schering Corporation	Combination treatments for chemokine-mediated diseases
PE20040570A1 (es)	2002-10-09	2004-08-30	Pharmacopeia Drug Discovery	Tiadiazoldioxidos y tiadiazoloxidos como ligandos del receptor de cxc- y cc-quimiocina
ES2308299T3 (es)	2003-12-19	2008-12-01	Schering Corp	Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas.
TW200530231A (en)	2003-12-22	2005-09-16	Schering Corp	Isothiazole dioxides as CXC-and CC-chemokine receptor ligands
EP1912971A2 (de)	2005-06-29	2008-04-23	Shering Corporation	Disubstituierte oxadiazole als liganden des cxc-chemokinrezeptors
MX2008000367A (es)	2005-06-29	2008-03-07	Schering Corp	Oxidiazolopirazinas y tiadiazolopirazinas 5,6-di-sustituidas como ligandos de receptor de quimiocina en la que dos cisternas son separadas por un solo aminoacido.
CN112789266A (zh) *	2018-09-27	2021-05-11	Fmc公司	用于制备除草剂哒嗪酮的中间体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA784639A (en) *		1968-05-07	C. Olson Harold	Herbicidal compositions
FR1441438A (fr) *	1963-11-13	1966-06-10	Basf Ag	Procédé pour la préparation de nitro-4 amino-5 pyridazones-6
FR1413955A (fr) *	1964-06-03	1965-10-15	Basf Ag	Procédé pour la préparation d'amino-4 halogéno-5 pyridazones-6
US4296120A (en) *	1980-08-28	1981-10-20	Pfizer Inc.	(Carboxy-oxo-pyrrolidino)phenylalkenamides and esters thereof as SRS-A antagonists
EP0186817B1 (de) *	1984-12-10	1989-08-02	Nissan Chemical Industries Ltd.	3(2H)Pyridazinon, Verfahren zu seiner Herstellung und dieses enthaltendes anti-allergisches Mittel
JPH0641454B2 (ja) *	1985-02-27	1994-06-01	日産化学工業株式会社	ピリダジノン誘導体
US4892947A (en) *	1985-04-27	1990-01-09	Nissan Chemical Industries Ltd.	3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it

1988
- 1988-01-15 US US07/144,173 patent/US4978665A/en not_active Expired - Fee Related
- 1988-01-15 HU HU88152A patent/HU198696B/hu not_active IP Right Cessation
- 1988-01-18 CA CA000556722A patent/CA1324792C/en not_active Expired - Fee Related
- 1988-01-18 ZA ZA880309A patent/ZA88309B/xx unknown
- 1988-01-19 DD DD88312298A patent/DD287497A5/de not_active IP Right Cessation
- 1988-01-19 AU AU10396/88A patent/AU597141B2/en not_active Ceased
- 1988-01-19 SU SU884355078A patent/SU1584750A3/ru active
- 1988-01-20 DE DE8888100798A patent/DE3876813D1/de not_active Expired - Fee Related
- 1988-01-20 EP EP88100798A patent/EP0275997B1/de not_active Expired - Lifetime
- 1988-01-20 AT AT88100798T patent/ATE83773T1/de not_active IP Right Cessation
- 1988-01-20 DE DE3876813T patent/DE3876813T4/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA1324792C (en)	1993-11-30
AU1039688A (en)	1988-07-21
EP0275997B1 (de)	1992-12-23
DE3876813D1 (de)	1993-02-04
US4978665A (en)	1990-12-18
ZA88309B (en)	1988-07-01
DE3876813T2 (de)	1993-04-29
HU198696B (en)	1989-11-28
EP0275997A1 (de)	1988-07-27
HUT46313A (en)	1988-10-28
DE3876813T4 (de)	1995-05-11
DD287497A5 (de)	1991-02-28
AU597141B2 (en)	1990-05-24
SU1584750A3 (ru)	1990-08-07

Legal Events

Date	Code	Title	Description
1993-06-15	UEP	Publication of translation of european patent specification
1997-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE83773T1 (de)	1993-01-15	3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
JPS568361A (en)	1981-01-28	Pyroglutamic acid derivative and analogue
FI892787A0 (fi)	1989-06-07	Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
MY102866A (en)	1993-03-31	Amide derivatives.
EP0787726A4 (de)	1997-08-06
TW368501B (en)	1999-09-01	7-(2-aminoethyl)-benzothiazolones
ATE57699T1 (de)	1990-11-15	Pyridoncarbonsauere-derivate und verfahren zu ihrer herstellung.
GB0018272D0 (en)	2000-09-13	Chemical compounds IV
DE69129175D1 (de)	1998-05-07	1-Methylcarbapenemderivate und Verfahren zu ihrer Herstellung
ATE44748T1 (de)	1989-08-15	4-substituierte 6-alkylidene-androsten-3,17-dion- derivate und verfahren zu ihrer herstellung.
CO4980887A1 (es)	2000-11-27	Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico
ATE53032T1 (de)	1990-06-15	2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
ES2073258T3 (es)	1995-08-01	Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
NZ221699A (en)	1990-03-27	Pyridazinone derivatives; pharmaceutical compositions and intermediates
GR3030234T3 (en)	1999-08-31	4-Phenylcarbamoyl-3-isoxazolecarboxylic acid derivatives with antiinflammatory activity
ES467069A1 (es)	1979-10-16	Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
MY109714A (en)	1997-04-30	Process for preparing 8-chloroquinolone derivatives
AP1518A (en)	2005-12-12	Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
ZA807337B (en)	1982-08-25	2-phenylamino-imidazolines-(2),processes for their preparation,and pharmaceutical compositions thereof
NZ504299A (en)	2001-01-26	1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them
ES479110A1 (es)	1979-07-01	Procedimiento para preparar derivados de benzamidina.
ATE52509T1 (de)	1990-05-15	Thiazolidinderivate und verfahren zu ihrer herstellung.
DE69303352D1 (de)	1996-08-01	Verfahren zur Herstellung 5-Pyrazolomerkaptan-Derivate und dessen zwischenprodukte
ATE53839T1 (de)	1990-06-15	2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
HUP0204144A2 (en)	2003-05-28	N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses